價格 | ¥306 | ¥466 | ¥913 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-02-28 |
中文名稱:化合物 GSK591 | 英文名稱:GSK591 |
CAS:1616391-87-7 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.77% | 產(chǎn)品類別: 抑制劑 |
貨號: T6853 |
名稱 | GSK591 |
描述 | GSK591 (GSK3203591), Alternative Names are EPZ015866, GSK3203591, is a potent selective inhibitor of the arginine methyltransferase PRMT5 (IC50=11 nM). |
激酶實驗 | Selectivity profiling experiments: The lysates (5 mg of total protein each) are preincubated with 0 (DMSO control), 2.5 nM, 25 nM, 250 nM, 2.5 μM or 25 μM free compound (GSK690693 or GSK2141795) on an end-over-end shaker for 45 min at 4 °C. Subsequently, lysates are incubated with beads (coupled Akt probe or kinobeads) for 1 h at 4 °C, for both qualitative and quantitative experiments. The beads are washed with 1× CP buffer and collected by centrifugation. Bound proteins are eluted with 2× NuPAGE LDS sample buffer, and eluates are reduced and alkylated by 50 mM dithiothreitol and 55 mM iodoacetamide. |
體外活性 | In an in vitro biochemical assay, GSK591 potently inhibits the PRMT5/MEP50 complex from methylating (histone) H4 with IC50 = 11 nM. In Z-138 cells, GSK591 inhibits the symmetric arginine methylation of SmD3 with EC50 = 56 nM. Further, GSK591 is selective for PRMT5 (up to 50 micromolar) relative to a panel of methyltransferases[1][2]. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 60 mg/mL (157.7 mM) |
關鍵字 | EPZ 015866 | GSK 591 | GSK591 | EPZ-015866 | Inhibitor | inhibit | GSK-3203591 | Histone Methyltransferase | GSK 3203591 | GSK-591 |
相關產(chǎn)品 | Tazemetostat hydrobromide | XY1 | MRTX-1719 | MAK683 | Tazemetostat | iso-Azalansta | EPZ015666 | UNC 0631 | AMI-1 free acid | MS37452 | MAK-683 hydrochloride | Piribedil |
相關庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 組蛋白修飾化合物庫 | 抗衰老化合物庫 | 抗COVID-19化合物庫 | 表觀遺傳庫 | NO PAINS 化合物庫 | 甲基化化合物庫 | 表型篩選靶點鑒定庫 |
成立日期 | 2013-04-18 (13年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
湖北威德利化學試劑有限公司
|
2025-04-22 | |
詢價 |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-04-22 | |
詢價 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-04-17 | |
¥3398.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2025-02-27 | |
詢價 |
VIP3年
|
陜西西化化學工業(yè)有限公司
|
2025-02-19 | |
詢價 |
VIP2年
|
德陽思諾生物科技有限公司
|
2025-01-07 |